Search Results 181-190 of 418 for ������������������KaKaoTalk:PC53������������������ ������ ������

  1. A Study to Develop a Biobank of Samples from Patients Undergoing Therapy with PCSK9 Inhibitors - Mayo Clinic

    Develop a biobank of samples from patients undergoing therapy with PCSK9 inhibitors (FDA- approved in 2015, therapeutics for hypercholesterolemia) with the goal ...

  2. A Study to Assess a New Personalized Tool for Colorectal Cancer Peritoneal Disease Treatment - Mayo Clinic

    About this study. The objectives of this study are to genomically characterize patient-derived organoids (PDOs) and primary tissues from colorectal ...

  3. Publications - Peter M. Pollak, M.D. - Mayo Clinic

    Ghannam A, Gharacholou SM, Ball CT, Pollak PM, Parikh PP, Landolfo C, Ali MT, Landolfo K. Characteristics and Outcomes After Transcatheter Aortic Valve ...

  4. Paget's disease of the breast - Doctors and departments - Mayo Clinic

    This rare form of breast cancer causes breast skin changes. Learn about the symptoms, causes, diagnosis and treatments, including surgery.

  5. Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies - Mayo Clinic

    The study will be conducted in three parts. Part 1 is a dose escalation phase to determine the maximum tolerated dose (MTD) of INCB040093, a PI3Kδ inhibitor, or ...

  6. Mayo Clinic Q&A - Dr. Gregory Poland - COVID-19 Update

    Dr. Halena Gazelka 00:43. Wow. Welcome everyone to Mayo Clinic Q&A. I'm your host, Dr. Halena Gazelka. We're recording this podcast and Monday, January the ...

  7. A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS) - Mayo Clinic

    Study CC-90002-AML-001 is an open-label, Phase 1 dose escalation (Part A) and expansion (Part B), clinical study of CC-90002, administered by intravenous (IV) ...

  8. Spinal arteriovenous malformation (AVM) - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  9. A Study Testing the Effectiveness and Safety of KPL-301 in Patients with Giant Cell Arteritis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. An Open-Label Pilot Study of KPL-914 in Recurrent Pericarditis - Mayo Clinic

    Part 1 enrolls symptomatic subjects with recurrent idiopathic pericarditis (RIP) with an elevated marker of systemic inflammation (C-reactive protein [CRP] > ...